Diabetes is currently one of the fastest-growing diseases facing our generation. In the U.S., diabetes’ prevalence is growing at an alarming rate, having doubled from around 11 million American cases in 2000 to around 22 million in 2014, according to the CDC. Because of the size of the market for diabetes medical devices and the high growth rate of the disease, there are a lot of eyes watching what’s happening and looking for ways to invest. Since diabetes is currently incurable, it’s a very expensive disease, particularly when it starts early in a person’s lifetime. Many medical device organizations, technology companies and entrepreneurs are looking to get their foot in the door.